Free Trial
NASDAQ:GDRX

GoodRx (GDRX) Stock Price, News & Analysis

GoodRx logo
$4.57 +0.04 (+0.77%)
As of 02:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About GoodRx Stock (NASDAQ:GDRX)

Advanced

Key Stats

Today's Range
$4.54
$4.73
50-Day Range
$3.47
$5.12
52-Week Range
$3.31
$7.20
Volume
1.55 million shs
Average Volume
2.20 million shs
Market Capitalization
$1.59 billion
P/E Ratio
45.65
Dividend Yield
N/A
Price Target
$5.80
Consensus Rating
Hold

Company Overview

GoodRx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

GDRX MarketRank™: 

GoodRx scored higher than 85% of companies evaluated by MarketBeat, and ranked 159th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GoodRx has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on 5 buy ratings, 7 hold ratings, and no sell ratings.

  • Upside Potential

    GoodRx has a consensus price target of $5.80, representing about 27.1% upside from its current price of $4.57.

  • Amount of Analyst Coverage

    GoodRx has only been the subject of 3 research reports in the past 90 days.

  • Read more about GoodRx's stock forecast and price target.
  • Earnings Growth

    Earnings for GoodRx are expected to grow by 38.46% in the coming year, from $0.13 to $0.18 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GoodRx is 45.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.50.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GoodRx is 45.65, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.71.

  • Price to Earnings Growth Ratio

    GoodRx has a PEG Ratio of 1.97. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    GoodRx has a P/B Ratio of 2.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about GoodRx's valuation and earnings.
  • Percentage of Shares Shorted

    6.86% of the float of GoodRx has been sold short.
  • Short Interest Ratio / Days to Cover

    GoodRx has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GoodRx has recently decreased by 16.32%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    GoodRx does not currently pay a dividend.

  • Dividend Growth

    GoodRx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.86% of the float of GoodRx has been sold short.
  • Short Interest Ratio / Days to Cover

    GoodRx has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GoodRx has recently decreased by 16.32%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    GoodRx has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for GoodRx this week, compared to 5 articles on an average week.
  • Search Interest

    12 people have searched for GDRX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GoodRx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $64,865.00 in company stock.

  • Percentage Held by Insiders

    Only 4.17% of the stock of GoodRx is held by insiders.

  • Percentage Held by Institutions

    63.77% of the stock of GoodRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about GoodRx's insider trading history.
Receive GDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GDRX Stock News Headlines

Get my No. 1 gold stock now
Gold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks say this is just the beginning... Because there's mounting evidence that a 40% market crash could be on the way.tc pixel
1 Healthcare Stock with Exciting Potential and 2 We Brush Off
GoodRx jumps 21% to $5.14 in late trading
See More Headlines

GDRX Stock Analysis - Frequently Asked Questions

GoodRx's stock was trading at $4.65 at the start of the year. Since then, GDRX shares have decreased by 1.8% and is now trading at $4.5650.

GoodRx Holdings, Inc. (NASDAQ:GDRX) released its earnings results on Wednesday, August, 6th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.10 by $0.01. The firm's revenue was up 1.2% on a year-over-year basis.
Read the conference call transcript
.

GoodRx (GDRX) raised $900 million in an IPO on Wednesday, September 23rd 2020. The company issued 34,600,000 shares at $24.00-$28.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays served as the underwriters for the IPO and BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI, Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus and Ramirez were co-managers.

Shares of GDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GoodRx investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/06/2025
Today
10/06/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:GDRX
CIK
1809519
Fax
N/A
Employees
950
Year Founded
2011

Price Target and Rating

High Price Target
$7.00
Low Price Target
$5.00
Potential Upside/Downside
+26.8%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.10
Trailing P/E Ratio
45.75
Forward P/E Ratio
35.19
P/E Growth
1.97
Net Income
$16.39 million
Net Margins
4.33%
Pretax Margin
6.97%
Return on Equity
8.86%
Return on Assets
4.50%

Debt

Debt-to-Equity Ratio
0.75
Current Ratio
4.21
Quick Ratio
4.21

Sales & Book Value

Annual Sales
$792.32 million
Price / Sales
2.01
Cash Flow
$0.32 per share
Price / Cash Flow
14.24
Book Value
$1.89 per share
Price / Book
2.42

Miscellaneous

Outstanding Shares
347,450,000
Free Float
332,961,000
Market Cap
$1.59 billion
Optionable
Optionable
Beta
1.23

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:GDRX) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners